Objectives: - Clinical applications of PLLA in combination with other treatment modalities for facial and body rejuvenation, as well as scars.

Objectives: To identify the cheekbones and jawlines as two parallel lines ("snatched lines") which can be treated simultaneously to create balance and overall improvement of facial features.

To be aware of the anatomic considerations of the cheekbones and jawline relevant to injectable treatments.

To learn how to safely and effectively combine therapies (fillers, threads and toxin) in order to treat these areas.

Objectives: The most promising areas for facial rejuvenation are the frontal and temporal areas.
Involution changes affect the frontal and temporal zones following fat packets involution, ptosis, retraction of temporal zone.

Introduction: The procedures of facial countering often need to start with the upper third of face.

Materials / method: This review is based on the authors clinical experience in treating the temporal and frontal areas for aesthetic purposes.

Results: The frontal area consists of 5 layers. The safest layer for injections of hyaluronic acid fillers is the supraperirest level. There are 10 layers in the temporal zone, and the safest method is an interfactional injection.
The report presents techniques of correction of the temporal and frontal areas to increase the volume and obtain the lifting effect, as well as techniques of the suspension lifting.

Conclusion: This report provides a detailed anatomical overview of the temple and forehead areas, describing safe injection techniques from an anatomical and aesthetic result perspective, as well as methods to avoidя unwanted effects during facial rejuvenation.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): Ipsen. Siam2024 . ECLM2024. PRO AGELESS 2023.

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): Ipsen. Siam2024 . ECLM2024. PRO AGELESS 2023.

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability